Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)

NCT00073255 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Diabetes Mellitus, Insulin-Dependent

Interventions

DRUG: hokt3g1 (ALA-ALA)

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)